Clinical Trial Update: Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating CAR.70-engineered IL-15-transduced cord blood-derived NK cells with lymphodepleting chemotherapy for advanced renal cell carcinoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Osteosarcoma
• Renal Cell Carcinoma

Drugs mentioned

• CAR.70-engineered IL-15-transduced cord blood-derived NK cells (CAR-NK cells with IL-15 transduction (cord blood-derived))

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Renal Cell Carcinoma, Advanced Mesothelioma | Phase 1, Phase 2 | Status: RECRUITING